An emerging immunotherapy treatment, chimeric antigen receptor (CAR) T-cell therapy can be very effective in treating patients with B-cell malignancies. However, knowledge gaps exist over the role of CAR T-cell therapy in the management of these patients. In an effort to close these gaps, i3 Health provided an NCPD-approved online strategy session titled Understanding and Optimizing CAR T-Cell Therapy for Patients With B-Cell Malignancies.A total of 539 participants completed this activity, incl...
The increased prevalence of technology in today's society has opened up numerous windows for alternative methods of continuing medical education (CME). However, according to a survey conducted by i3 Health at the 67th Society of Government Service Urologists (SGSU) Kimbrough Urological Seminar held in Charlotte, North Carolina, in January 2020, live meetings still remain the preferred CME format among urologists.Surveys were completed by 36 individuals, of whom 35 (97.2%) were physicians and oth...
We had some thought-provoking conversations with our CME colleagues at Alliance 2020. As we reflect on our takeaways from the conference, there's one underlying question that makes us hopeful, perplexed, and excited all at the same time. Our team at i3 Health wants to know…What will the future landscape of the CME industry look like? Here are some of the trends that we've picked up on from the musings of the CME community at Alliance 2020:1. Increasing standards for outcomesEverything...
i3 Health staff attended the 9th annual conference of the Mid-Atlantic Alliance for Continuing Medical Education (MAACME) last week in Harrisburg, PA. This year's conference featured interactive sessions facilitated by experienced CME thought leaders. Topics included updates from the ACCME, grant funding, best practices for needs assessments, evolving technology in education, and much more!This small-scale conference leaves a big impact for those in attendance. MAACME is a great place for us to ...
Carcinoid syndrome occurs when carcinoid tumors secrete serotonin or other chemicals into the bloodstream. Because primary symptoms of carcinoid syndrome are associated with other more common diseases, timely recognition is difficult, negatively impacting patients' quality of life and functioning. A CNE-approved Oncology Nursing Strategy Session, Optimizing Management of Carcinoid Syndrome in Patients With Neuroendocrine Tumors, revealed meaningful improvements in nurses' knowledge surrounding r...